Lee EQ, Zhang P, Wen PY, Gerstner ER, et al. NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma. Cancer 2020 Mar 10. doi: 10.1002/cncr.32811.
PMID: 32154928